Avenue Therapeutics, Inc. total revenue, net income and dynamics of changes in US dollar today
Avenue Therapeutics, Inc. revenue for the past few reporting periods. Net income of Avenue Therapeutics, Inc. today amounted to -998 000 $. The dynamics of net income of Avenue Therapeutics, Inc. has changed by -5 000 $ in recent years. The financial graph of Avenue Therapeutics, Inc. displays the online status: net income, net revenue, total assets. The value of "net income" Avenue Therapeutics, Inc. on the graph is displayed in blue. All information on Avenue Therapeutics, Inc. total revenue on this chart is created in the form of yellow bars.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
31/03/2021
0 $
-
-998 000 $
-
31/12/2020
0 $
-
-993 000 $
-
30/09/2020
0 $
-
-1 028 000 $
-
30/06/2020
0 $
-
-1 888 000 $
-
30/09/2019
0 $
-
-2 242 000 $
-
30/06/2019
0 $
-
-6 982 000 $
-
31/03/2019
0 $
-
-11 269 000 $
-
31/12/2018
0 $
-
-3 919 000 $
-
Show:
to
Avenue Therapeutics, Inc. financial report charts
The dates of the latest financial statements of Avenue Therapeutics, Inc.: 31/12/2018, 31/12/2020, 31/03/2021. The dates of the financial statements are determined by the accounting rules. The latest financial report of Avenue Therapeutics, Inc. is available online for such a date - 31/03/2021. Operating income Avenue Therapeutics, Inc. is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Avenue Therapeutics, Inc. is -1 001 000 $
Avenue Therapeutics, Inc. quarterly report dates
Net income Avenue Therapeutics, Inc. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Avenue Therapeutics, Inc. is -998 000 $ Current assets Avenue Therapeutics, Inc. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Avenue Therapeutics, Inc. is 1 944 000 $ Total assets Avenue Therapeutics, Inc. refers to the total amount of assets owned by a person or entity. Total assets Avenue Therapeutics, Inc. is 1 944 000 $
Current cash Avenue Therapeutics, Inc. - the sum of all of the cash a company has on the date of report. Current cash Avenue Therapeutics, Inc. is 1 825 000 $
31/03/2021
31/12/2020
30/09/2020
30/06/2020
30/09/2019
30/06/2019
31/03/2019
31/12/2018
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
-
-
-
-
-
-
-
-
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
-
-
-
-
-
-
-
-
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
-
-
-
-
-
-
-
-
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
-
-
-
-
-
-
-
-
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
-1 001 000 $
-999 000 $
-1 037 000 $
-1 903 000 $
-2 323 000 $
-7 108 000 $
-11 360 000 $
-4 102 000 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
-998 000 $
-993 000 $
-1 028 000 $
-1 888 000 $
-2 242 000 $
-6 982 000 $
-11 269 000 $
-3 919 000 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
258 000 $
484 000 $
466 000 $
1 219 000 $
1 706 000 $
6 392 000 $
10 241 000 $
2 715 000 $
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
1 001 000 $
999 000 $
1 037 000 $
1 903 000 $
2 323 000 $
7 108 000 $
11 360 000 $
4 102 000 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
1 944 000 $
3 245 000 $
4 352 000 $
5 331 000 $
13 878 000 $
15 677 000 $
29 763 000 $
4 525 000 $
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
1 944 000 $
3 245 000 $
4 352 000 $
5 331 000 $
13 878 000 $
15 677 000 $
29 763 000 $
4 525 000 $
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
1 825 000 $
3 132 000 $
4 325 000 $
5 257 000 $
8 741 000 $
10 455 000 $
29 448 000 $
2 671 000 $
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
-
-
-
-
1 917 000 $
1 773 000 $
9 412 000 $
5 156 000 $
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
-
-
-
-
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
-
-
-
-
1 917 000 $
1 773 000 $
9 412 000 $
5 156 000 $
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
-
-
-
-
13.81 %
11.31 %
31.62 %
113.94 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
1 475 000 $
2 359 000 $
3 234 000 $
4 101 000 $
11 961 000 $
13 904 000 $
20 351 000 $
-631 000 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-
-
-
-
-1 714 000 $
-13 981 000 $
-5 568 000 $
-1 238 000 $
Last revenue report of Avenue Therapeutics, Inc. was 31/03/2021. According to last financial report total revenue in Avenue Therapeutics, Inc. was 0 US dollar and changed by 0% since last year. Net income in Avenue Therapeutics, Inc. was -998 000 $ in last quartal, net income changes to 0%.
Avenue Therapeutics, Inc. stocks data
ATXI stock price
Avenue Therapeutics, Inc. stock price today, ATXI stock quote.
